Daniel P Giovenco1, David Hammond2, Catherine G Corey3, Bridget K Ambrose3, Cristine D Delnevo4. 1. Center for Tobacco Studies, Rutgers University-School of Public Health, New Brunswick, NJ; d.giovenco@rutgers.edu. 2. Department of Health Studies, University of Waterloo-School of Public Health and Health Systems, Waterloo, ON, Canada; 3. Center for Tobacco Products, U.S. Food and Drug Administration; Silver Spring, MD. 4. Center for Tobacco Studies, Rutgers University-School of Public Health, New Brunswick, NJ;
Abstract
INTRODUCTION: E-cigarette sales continue to increase in the United States. To date, little surveillance research has documented the specific product attributes driving growth. This study uses national market scanner data to describe sales trends in traditional U.S. tobacco retail channels between 2012 and 2013 and identifies product features associated with sales increases. METHODS: Data on e-cigarette sales in convenience stores, drug stores, grocery stores, and mass merchandisers in the United States were obtained from the Nielsen Company. Each product was coded for attributes such as brand, flavor, and unit size. Total sales volume, market share, and percent growth were calculated for various product attributes. RESULTS: E-cigarette sales more than doubled between 2012 and 2013, from $273.6 million to $636.2 million, respectively. Growth was particularly strong in the convenience store channel. Blu eCigs quickly emerged as the best-selling brand and in 2013 constituted nearly half (44.1%) of overall sales. Although fruit-flavored and other flavored products experienced marked growth, unflavored and menthol e-cigarettes overwhelmingly dominated the market. Sales of single unit products (likely disposable e-cigarettes) increased by 216.4%, a much faster rate than multi-unit packs and cartridge refills. CONCLUSIONS: In traditional U.S. retail channels, particularly the convenience store channel, sales of e-cigarettes continue to grow, with brands like blu and disposable products as the likely drivers. Given the rapidly-changing market, expanded surveillance is needed to monitor sales not only in traditional retail locations, but sales online and in specialty "vape shops," as well.
INTRODUCTION: E-cigarette sales continue to increase in the United States. To date, little surveillance research has documented the specific product attributes driving growth. This study uses national market scanner data to describe sales trends in traditional U.S. tobacco retail channels between 2012 and 2013 and identifies product features associated with sales increases. METHODS: Data on e-cigarette sales in convenience stores, drug stores, grocery stores, and mass merchandisers in the United States were obtained from the Nielsen Company. Each product was coded for attributes such as brand, flavor, and unit size. Total sales volume, market share, and percent growth were calculated for various product attributes. RESULTS: E-cigarette sales more than doubled between 2012 and 2013, from $273.6 million to $636.2 million, respectively. Growth was particularly strong in the convenience store channel. Blu eCigs quickly emerged as the best-selling brand and in 2013 constituted nearly half (44.1%) of overall sales. Although fruit-flavored and other flavored products experienced marked growth, unflavored and menthol e-cigarettes overwhelmingly dominated the market. Sales of single unit products (likely disposable e-cigarettes) increased by 216.4%, a much faster rate than multi-unit packs and cartridge refills. CONCLUSIONS: In traditional U.S. retail channels, particularly the convenience store channel, sales of e-cigarettes continue to grow, with brands like blu and disposable products as the likely drivers. Given the rapidly-changing market, expanded surveillance is needed to monitor sales not only in traditional retail locations, but sales online and in specialty "vape shops," as well.
Authors: Jennifer L Pearson; Amanda Richardson; Raymond S Niaura; Donna M Vallone; David B Abrams Journal: Am J Public Health Date: 2012-07-19 Impact factor: 9.308
Authors: Jessica M Yingst; Susan Veldheer; Shari Hrabovsky; Travis T Nichols; Stephen J Wilson; Jonathan Foulds Journal: Nicotine Tob Res Date: 2015-03-05 Impact factor: 4.244
Authors: Andrea C Villanti; Amanda L Johnson; Bridget K Ambrose; K Michael Cummings; Cassandra A Stanton; Shyanika W Rose; Shari P Feirman; Cindy Tworek; Allison M Glasser; Jennifer L Pearson; Amy M Cohn; Kevin P Conway; Raymond S Niaura; Maansi Bansal-Travers; Andrew Hyland Journal: Am J Prev Med Date: 2017-03-16 Impact factor: 5.043
Authors: Travis T Nichols; Jonathan Foulds; Jessica M Yingst; Susan Veldheer; Shari Hrabovsky; John Richie; Thomas Eissenberg; Stephen J Wilson Journal: Brain Res Bull Date: 2015-10-23 Impact factor: 4.077
Authors: Cati G Brown-Johnson; Andrea Burbank; Eric J Daza; Arianna Wassmann; Amy Chieng; Geoffrey W Rutledge; Judith J Prochaska Journal: Am J Prev Med Date: 2016-08-26 Impact factor: 5.043
Authors: Shyanika W Rose; Amanda L Johnson; Allison M Glasser; Andrea C Villanti; Bridget K Ambrose; Kevin Conway; K Michael Cummings; Cassandra A Stanton; Cristine Delnevo; Olivia A Wackowski; Kathryn C Edwards; Shari P Feirman; Maansi Bansal-Travers; Jennifer Bernat; Enver Holder-Hayes; Victoria Green; Marushka L Silveira; Yitong Zhou; Haneen Abudayyeh; Andrew Hyland Journal: Tob Control Date: 2019-09-21 Impact factor: 7.552
Authors: Andrew A Strasser; Valentina Souprountchouk; Amanda Kaufmann; Sonja Blazekovic; Frank Leone; Neal L Benowitz; Robert A Schnoll Journal: Tob Regul Sci Date: 2016-10